B. Riley analyst John Massocca raised the firm’s price target on Diversified Healthcare Trust (DHC) to $8.50 from $6.50 and keeps a Buy rating on the shares. The firm says the company’s 2026 outlook is an indicator of its “value growth potential.” It sees the stock’s discount to peers as “too severe.”
Claim 70% Off TipRanks Premium
-
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-
Stay ahead of the market with the latest news and analysis and maximize your portfolio’s potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DHC:
Disclaimer & DisclosureReport an Issue
-
Diversified Healthcare Trust Highlights Strong 2025 Performance Outlook
-
Is DHC a Buy, Before Earnings?
-
The Week That Was, The Week Ahead: Macro and Markets, Jan. 25
-
Diversified Healthcare Trust Gains Cash from AlerisLife Wind-Down
-
Diversified Healthcare Trust Reshapes Senior Living Operations
Leave a Reply